for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Wright Medical Group NV

WMGI.O

Latest Trade

29.78USD

Change

0.34(+1.15%)

Volume

7,828,967

Today's Range

29.65

 - 

30.07

52 Week Range

19.04

 - 

32.86

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
29.44
Open
29.65
Volume
7,828,967
3M AVG Volume
107.06
Today's High
30.07
Today's Low
29.65
52 Week High
32.86
52 Week Low
19.04
Shares Out (MIL)
126.90
Market Cap (MIL)
3,735.97
Forward P/E
171.46
Dividend (Yield %)
--

Next Event

Q4 2019 Wright Medical Group NV Earnings Release

Latest Developments

More

Wright Medical Group NV Q2 Loss Per Share $0.15 From Continuing Operations

Wright Medical Group Reports Q1 Loss Per Share $0.24 From Continuing Operations

Wright Medical Group N.V. Reports Fourth Quarter Results, Provides 2019 Guidance

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Wright Medical Group NV

Wright Medical Group N.V. is a medical device company. The Company is focused on extremities and biologics products. The Company's segments include U.S. Lower Extremities & Biologics, U.S. Upper Extremities and International Extremities & Biologics. Its product portfolio consists of product categories, such as Upper extremities, which includes joint implants and bone fixation devices for the shoulder, elbow, wrist, and hand; Lower extremities, which includes joint implants and bone fixation devices for the foot and ankle; Biologics, which includes products used to support treatment of damaged or diseased bone, tendons, and soft tissues or to stimulate bone growth, and Sports medicine and other, which includes products used across several anatomic sites to mechanically repair tissue-to-tissue or tissue-to-bone injuries and other ancillary products.

Industry

Medical Equipment & Supplies

Contact Info

Prins Bernhardplein 200

+31.20.6754002

http://www.wright.com/

Executive Leadership

David D. Stevens

Non-Executive Independent Chairman of the Board

Robert J. Palmisano

President and Chief Executive Officer, Executive Director

Lance A. Berry

Executive Vice President, Chief Financial and Operations Officer

Andrew C. Morton

Senior Vice President, Chief Human Resources Officer

Kevin D. Cordell

Executive Vice President, Chief Global Commercial Officer

Key Stats

2.62 mean rating - 13 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.7K

2017

0.7K

2018

0.8K

2019(E)

0.9K
EPS (USD)

2016

-0.440

2017

-0.220

2018

0.000

2019(E)

0.172
Price To Earnings (TTM)
--
Price To Sales (TTM)
4.10
Price To Book (MRQ)
4.39
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
135.82
LT Debt To Equity (MRQ)
85.89
Return on Investment (TTM)
-6.12
Return on Equity (TTM)
-4.05

Latest News

Latest News

Stryker boosts bone implants with $4 billion Wright Medical buyout

Medical device maker Stryker Corp <SYK.N> said on Monday it would buy smaller rival Wright Medical Group <WMGI.O> for about $4 billion (£3.1 billion) in cash, expanding into the fast-growing business of implants for shoulders and wrists.

Medical device maker Stryker to buy Wright Medical for $4 bln

Medical device maker Stryker Corp said on Monday it would buy smaller rival Wright Medical Group for about $4 billion in cash.

BRIEF-Wright Medical Group Reports Q1 Loss Per Share $0.19 From Continuing Operations

* WRIGHT MEDICAL GROUP N.V. REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS

BRIEF-Wright Medical Group Reports Q4 EPS $0.25 From Cont Ops

* WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE

BRIEF-Wright Medical Group ‍Q4 Net Sales $218 Million​

* WRIGHT MEDICAL GROUP N.V. REPORTS 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS AND PROVIDES 2018 ANNUAL GUIDANCE

BRIEF-Wright Medical Group buys IMASCAP SAS for $88.8 mln

* WRIGHT MEDICAL GROUP N.V. ANNOUNCES ACQUISITION OF IMASCAP SAS

BRIEF-Wright Medical Q3 loss per share $0.33 from continuing operations

* Wright medical group n.v. Reports 2017 third quarter financial results and updated 2017 annual guidance

BRIEF-Wright Medical Group ‍agreed on a comprehensive settlement intended to resolve substantially all remaining metal-on-metal hip claims

* Wright Medical Group - on October 3, co agreed on a comprehensive settlement intended to resolve substantially all remaining metal-on-metal hip claims

BRIEF-Wright Medical Group N.V. Q2 loss per share $0.20

* Wright Medical Group N.V. reports 2017 second quarter financial results

BRIEF-Wright Medical Group Q1 loss per share $0.35 from cont ops

* Wright Medical Group N.V. Reports 2017 first quarter financial results

BRIEF-Wright MEDICAL GROUP N.V. reports Q4 sales $193 million

* Wright Medical Group N.V. Reports 2016 fourth quarter and full-year financial results and provides 2017 guidance

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up